Peter F. Orio - Concepedia

Author

Peter F. Orio

Also Known As

P F Orio, P. F. Orio, P. Orio, P.F. Orio, P.F. Orio III, Peter F Orio, Peter F. Orio, Peter F. Orio III, Peter Orio, Peter Orio Ⅲ

237

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Brigham and Women's Hospital Dana-Farber Cancer Institute Dana-Farber Brigham Cancer Center Harvard University The University of Texas MD Anderson Cancer Center

About

Peter F. Orio is an author at Brigham and Women's Hospital specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	30	1.1K
2	Health Sciences	6	6	109
3	Engineering	3	3	108
4	Public Health	3	3	116
5	Nursing	2	2	79

Peter F. Orio

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience John E. Sylvester, Peter Grimm, John C. Blasko, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyUrologySeattle ExperienceRadiation TherapyMedicine	2006	213
Incidence and Predictors of Upgrading and Up Staging among 10,000 Contemporary Patients with Low Risk Prostate Cancer Kathryn T. Dinh, Brandon A. Mahal, David R. Ziehr, The Journal of Urology	2015	125
Clinical and Genomic Characterization of Low–Prostate-specific Antigen, High-grade Prostate Cancer Brandon A. Mahal, David D. Yang, Natalie Q. Wang, European Urology Prognostic BiomarkersUrologyOncologyGenitourinary CancerMedicine	2018	98
Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy Neil Mariados, Peter F. Orio, Zvi Schiffman, JAMA Oncology	2023	80
Radiation Dose to the Intraprostatic Urethra Correlates Strongly With Urinary Toxicity After Prostate Stereotactic Body Radiation Therapy: A Combined Analysis of 23 Prospective Clinical Trials Jonathan E. Leeman, Yu‐Hui Chen, Paul J. Catalano, International Journal of Radiation OncologyBiologyPhysics UrologyEngineeringRadiation TherapyBrachytherapyRadiation Dose	2021	67
Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer Yu‐Wei Chen, Brandon A. Mahal, Vinayak Muralidhar, International Journal of Radiation OncologyBiologyPhysics	2015	58
Implementing patient-reported outcome surveys as part of routine care: lessons from an academic radiation oncology department Lisa S. Rotenstein, Ankit Agarwal, Kelly O’Neil, Journal of the American Medical Informatics Association Family MedicineClinical Decision-makingTreatment Plan EvaluationPro CollectionPrimary Care	2017	58
Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3 + 4 Favorable Intermediate-risk Prostate Cancer David D. Yang, Brandon A. Mahal, Vinayak Muralidhar, European Urology Focus UrologyGenitourinary CancerMedicinePathologyProstatic Disease	2017	54
Prostate Brachytherapy Case Volumes by Academic and Nonacademic Practices: Implications for Future Residency Training Peter F. Orio, Paul L. Nguyen, Ivan Buzurović, International Journal of Radiation OncologyBiologyPhysics UrologyFuture Residency TrainingBrachytherapyContinuing Medical EducationProstatic Disease	2016	53
Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer Paul L. Nguyen, Neil E. Martin, Voleak Choeurng, Prostate Cancer and Prostatic Diseases	2017	53

Page 1